FDA approves one-of-a-kind drug for 9-year-old in Boulder
DENVER— A 9-year-old Boulder girl with a neurological disease is being treated with a one-of-a-kind drug designed specifically for her. The Colorado Sun reports that it's the first time the U.S. Food and Drug Administration has approved a drug for a single person, and it's an example of what the future might hold for precision medicine.